Pharma-Bio Serv (PBSV) Current Assets (2010 - 2026)

Pharma-Bio Serv has reported Current Assets for 16 years, with the latest figure at $13.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 14.23% year-over-year to $13.3 million; the trailing twelve-month figure through Jan 2026 stood at $13.3 million (down 14.23% YoY), and the FY2025 full-year result was $13.4 million, down 14.73% from the prior year.
• Current Assets for Q1 2026 stood at $13.3 million, roughly flat from $13.4 million in the prior quarter.
• The five-year high for Current Assets was $21.0 million in Q1 2022, with the low at $13.2 million in Q3 2025.
• Historically, Current Assets has averaged $17.3 million across 5 years, with a median of $18.8 million in 2024.
• Annual changes were most pronounced in 2022 — Current Assets fell 28.52% — and 2023, when it gained 0.75%.
• Pharma-Bio Serv's Current Assets stood at $19.9 million in 2022, then fell by 2.72% to $19.4 million in 2023, then fell by 19.08% to $15.7 million in 2024, then declined by 14.73% to $13.4 million in 2025, then slipped by 0.47% to $13.3 million in 2026.
• The last three Current Assets figures came in at $13.3 million (Q1 2026), $13.4 million (Q4 2025), and $13.2 million (Q3 2025), per Business Quant data.